TEGIRIX Trademark

Trademark Overview


On Wednesday, December 10, 1997, a trademark application was filed for TEGIRIX with the United States Patent and Trademark Office. The USPTO has given the TEGIRIX trademark a serial number of 75403017. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, September 16, 1999. This trademark is owned by SmithKline Beecham Biologicals S.A.. The TEGIRIX trademark is filed in the Pharmaceutical Products category with the following description:

human vaccines

General Information


Serial Number75403017
Word MarkTEGIRIX
Filing DateWednesday, December 10, 1997
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, September 16, 1999
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Serviceshuman vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 6, 1998
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSmithKline Beecham Biologicals S.A.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressB-1330 Rixensart
BE

Trademark Events


Event DateEvent Description
Thursday, September 16, 1999ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, October 20, 1998NON-FINAL ACTION MAILED
Monday, October 19, 1998PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, August 11, 1998APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 7, 1998ASSIGNED TO EXAMINER

Related Keywords


tegirix vaccines human